TUBA4A and neoplasm: It was found that high expression of ZYX, GJA1, and TUBA4A indeed correlated well with low sensitivity of tumor cells to DOX and, moreover, to another anticancer drugs, such as vincristine, topotecan, panobinostat, and cytarabine (Figure 6D).